Key result
Noninvasive continuous heart monitoring devices promise more proactive and equitable cardiovascular care, although challenges regarding usability and clinician trust remain.
Noninvasive continuous heart monitoring devices offer proactive care opportunities but face challenges regarding usability and clinician trust.
A new generation of noninvasive, FDA-cleared devices is making continuous heart monitoring more accessible to address cardiovascular disease. As healthcare shifts toward outcomes-based models, these technologies promise more proactive, equitable monitoring and care, though challenges around ease of usability and clinician trust persist.
No takes yet. Share an insight, caveat, or question.
Kristina Grifantini (2026) studied this question. Noninvasive continuous heart monitoring devices promise more proactive and equitable cardiovascular care, although challenges regarding usability and clinician trust remain.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: